QTTB today
$8.79-$0.41 (-4.46%)close Nov 12, 2026Trend
DailyUptrend (starting)
4 hourLeaning Bearish
1 hourStrong Bullish
15 minBullish
5 minStrong Bearish
Daily trend turns down below $7.28
Key levels
Resistance$10.45
Resistance$9.74
Support$8.22
Support$7.28
Latest news & SEC filings
EarningsQ32 Bio Posts Financials for Q3 2026
SEC FilingQ32 Bio Inc. filed a report on a major company event (Form 8-K)
All QTTB news →About Q32 Bio
Q32 Bio develops biologic drugs for immune and inflammatory disorders and is still in the testing phase. Its main candidate, bempikibart, is an antibody that targets IL-7 and TSLP signaling and is under study for alopecia areata. The firm also holds a complement inhibitor program focused on specific tissues, with ADX-096 among its assets, and it divested ADX-097 to Akebia Therapeutics.
Based on the company's 10-K filed Mar 10, 2026.
Nasdaq · Healthcare
Q32 Bio Inc. (QTTB)
What Is the Price Target for QTTB?
SEPT Low Target
$28.90
SEPT Mid Target
$34.00
SEPT High Target
$39.10
Analyst Consensus
$34.00
Is QTTB a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for QTTB.
Start Free Trial →Is QTTB Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, PEG, Analyst Consensus
Fair Value
$22.32
47
Moat Score
NARROW
4/9
Piotroski Score
1.0
Altman Z-Score
What Is Smart Money Doing with QTTB?
Insider Signal
NEUTRAL
4 buys / 6 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Morrison Jodie Pope | director officer | Sale | 3,221 | $27K | Oct 6, 2026 |
| Kalowski Lee | officer | Sale | 1,301 | $11K | Oct 6, 2026 |
| Violette Shelia M. | officer | Sale | 917 | $8K | Oct 6, 2026 |
| Kalowski Lee | officer | Sale | 3,972 | $66K | Aug 25, 2026 |
| Morrison Jodie Pope | director officer | Sale | 9,845 | $163K | Aug 25, 2026 |
| Violette Shelia M. | officer | Sale | 2,798 | $46K | Aug 25, 2026 |
| Xu Diyong | director 10% owner | Buy | 1,250,000 | $10.0M | May 28, 2026 |
| Xu Diyong | director 10% owner | Buy | 625,000 | $5.0M | May 28, 2026 |
| ORBIMED ADVISORS LLC | director 10% owner | Buy | 1,250,000 | $10.0M | May 28, 2026 |
| ORBIMED ADVISORS LLC | director 10% owner | Buy | 625,000 | $5.0M | May 28, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →QTTB Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
136.78%
FCF Growth YoY
50.5%
Revenue Trend
UNKNOWN
Dark Pool Trades for QTTB
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for QTTB, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 14:58:20 | $8.75 | 1,000 | $$9K | SELL |
| 14:56:12 | $8.76 | 1,000 | $$9K | SELL |
| 14:54:20 | $8.81 | 1,200 | $$11K | BUY |
| 14:48:07 | $8.86 | 1,081 | $$10K | SELL |
| 14:42:09 | $8.92 | 2,000 | $$18K | SELL |
5 dark pool trades shown · $$55K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Q32 Bio Inc. (QTTB) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →QTTB — frequently asked questions
What is QTTB stock price today?
Q32 Bio Inc. (QTTB) is at $8.79, down 4.46% (-$0.41) at the Nov 12, 2026 close.
Why is QTTB stock moving today?
Latest QTTB news — Nov 4, 2026: Q32 Bio Posts Financials for Q3 2026 · Nov 4, 2026: Q32 Bio Inc. filed a report on a major company event (Form 8-K)
What is the QTTB price target?
The average analyst price target for QTTB is $34.00, ranging from $13 to $66, based on 7 analysts. Latest: Jefferies initiates on Sep 28, 2026.
What do analysts rate QTTB?
Analyst ratings for QTTB: 1 Buy, 7 Hold, 0 Sell — consensus Hold.
Did QTTB beat earnings?
QTTB last reported on Aug 5, 2026: EPS -$0.44 vs -$0.53 expected — a beat of 17.0%.
What is QTTB's P/E ratio?
QTTB trades at a P/E of 3.4.
Does QTTB pay a dividend?
QTTB does not currently pay a dividend.
What are QTTB support and resistance levels?
Support: $8.22, $7.28, $6.59. Resistance: $9.74, $10.45, $11.41.
What are insiders doing with QTTB?
Insider activity: NEUTRAL, 4 buys and 6 sells in the last 90 days.
What is the latest news on QTTB?
Nov 4, 2026: Q32 Bio Posts Financials for Q3 2026 · Nov 4, 2026: Q32 Bio Inc. filed a report on a major company event (Form 8-K)